SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-24-001821
Filing Date
2024-11-15
Accepted
2024-11-15 17:20:24
Documents
20
Period of Report
2024-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e6129_8-k.htm   iXBRL 8-K 35422
2 EXHIBIT 4.1 e6129_ex4-1.htm EX-4.1 99220
3 EXHIBIT 10.1 e6129_ex10-1.htm EX-10.1 88472
4 EXHIBIT 10.2 e6129_ex10-2.htm EX-10.2 209872
5 EXHIBIT 10.3 e6129_ex10-3.htm EX-10.3 38130
6 EXHIBIT 99.1 e6129_ex99-1.htm EX-99.1 9292
7 EXHIBIT 99.2 e6129_ex99-2.htm EX-99.2 9339
8 GRAPHIC image_001.jpg GRAPHIC 3832
  Complete submission text file 0001731122-24-001821.txt   794881

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE vrpx-20241112.xsd EX-101.SCH 3027
10 XBRL LABEL FILE vrpx-20241112_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE vrpx-20241112_pre.xml EX-101.PRE 24173
22 EXTRACTED XBRL INSTANCE DOCUMENT e6129_8-k_htm.xml XML 3810
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 241468942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)